The effect of botulinum toxin type A combined with infrared polarized light for the treatment of chronic migraine
10.3760/cma.j.issn.0254-1424.2012.03.016
- VernacularTitle:A型肉毒毒素注射联合红外偏振光治疗慢性偏头痛的疗效观察
- Author:
Jinhui SONG
;
Xudong DING
;
Li HUANG
;
Yan HONG
;
Huaxian CHEN
;
Guibing ZHANG
- Publication Type:Journal Article
- Keywords:
Ultrasonography,Doppler,color;
Ultrasonography,interventional;
Migraine,chronic;
Botulinum toxin,type A;
Infrared polarized light
- From:
Chinese Journal of Physical Medicine and Rehabilitation
2012;34(3):216-219
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy and safety of local injection of botulinum toxin A ( BTX-A ) combined with infrared polarized light for patients with chronic migraine ( CM ). Methods Ninety-one patients with CM were randomly divided into 4 groups.Group A served as the control group in which Nimodipine was used to treat CM ( n =22 ) ; in group B infrared polarized light was used to irradiate the area of the CM for 50 to 60 d ( n =22 ) ; in group C subcutaneous injections of BTX-A were used ( n =24 ) ; and in group D infrared polarized light irradiation of the affected area was combined with subcutaneous injections of BTX-A ( n =23 ).The onset of headaches,their severity,quality of life,as well as side effects were recorded using the migraine disability assessment scale (MIDAS) and the short form of the medical outcomes study form (MOS-SF).The results obtained before and after 6 months of treatment were compared. Results Both of MIDAS and MOS-SF assessment showed significant differences before treatment and after 1,3 and 6 months of treatment in all groups.After 1,3 and 6 months of treatment,the MIDSA and MOS-SF results revealed statistically significant differences between groups A and D,as well as between groups B and C. Conclusion BTX-A injection combined with infrared polarized light exerts significant therapeutic effects on CM with few side effects.
